Showing results (61-70 of 519) with videos related to
Sort By:
Pageof 52
Brain Research|June 12, 1995
Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawalI Nylander, M Vlaskovska, L TereniusPsychopharmacology|August 31, 1977
Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolitesL Terenius, A Wahlström, H AgrenArchives of General Psychiatry|August 1, 1985
Endorphin activity in childhood psychosis. Spinal fluid levels in 24 casesC Gillberg, L Terenius, G LönnerholmJournal of Neuroscience Methods|August 1, 1985
Enzyme-linked immunosorbent assay of substance P and its metabolite SP 1-7. A comparison with RIAR Folkesson, A Neil, L TereniusNeuroscience Letters|December 16, 1987
Beta-adrenoceptor, vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) receptors functionally coupled to adenylate cyclase in the human neuroblastoma SK-N-MC cell lineM Olasmaa, S Påhlman, L TereniusScandinavian Journal of Haematology|November 1, 1978
Effects of prednisolone in 6 cases of glucocorticoid receptor-positive CLLB Simonsson, L Terenius, K NilssonLife Sciences|December 3, 1984
Substance P levels in various regions of the rat central nervous system after acute and chronic morphine treatmentL Bergström, T Sakurada, L TereniusPsychiatry Research|December 1, 1990
Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patientsL Heikkilä, R Rimón, L TereniusPeptides|September 22, 2000
Nociceptin/orphanin FQ metabolism and bioactive metabolitesL Terenius, J Sandin, T SakuradaPsychopharmacology|April 1, 1995
The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley ratsI Nylander, M Vlaskovska, L TereniusPageof 52